Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115,244,363
-
Total 13F shares
-
65,110,721
-
Share change
-
-3,739,346
-
Total reported value
-
$1,468,682,032
-
Put/Call ratio
-
10%
-
Price per share
-
$22.57
-
Number of holders
-
191
-
Value change
-
-$90,108,711
-
Number of buys
-
86
-
Number of sells
-
113
Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q3 2016
As of 30 Sep 2016,
GLOBUS MEDICAL INC - Class A Stock (GMED) was held by
191 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
65,110,721 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, JANUS CAPITAL MANAGEMENT LLC, OAK RIDGE INVESTMENTS LLC, Bank of New York Mellon Corp, Van Berkom & Associates Inc., BlackRock Fund Advisors, ABERDEEN ASSET MANAGEMENT PLC/UK, Consonance Capital Management LP, and BlackRock Institutional Trust Company, N.A..
This page lists
191
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.